Axial Therapeutics announced that A. Stewart Campbell, Ph.D., chief executive officer, will participate in a panel titled “Placing Patients...

Read more
By: Kairos Ventures On: April 28, 2022 In: Amorphology, Portfolio News

Amorphology has partnered with AddiTec to develop the additive manufacturing of multi-metal gear components for robotics.

Read more

Chimera Bioengineering is having a big week. The San Francisco-based biotherapeutics company announced Thursday that it has won the Asian Fund for...

Read more
By: Kairos Ventures On: April 28, 2022 In: Delpor, Portfolio News

Delpor announced that it has initiated and dosed the first subjects in a phase 1 clinical trial of DLP-160,...

Read more
By: Kairos Ventures On: April 27, 2022 In: Amorphology, Portfolio News

Amorphology, a NASA spinoff company, is a leader in the application of advanced materials and manufacturing technologies for the...

Read more
By: Kairos Ventures On: April 11, 2022 In: Linnaeus, Portfolio News

Linnaeus Therapeutics, Inc. announced that the laboratory of Gary Schwartz, MD at Columbia University Irving Medical Center presented new findings...

Read more

Axial Therapeutics announced that its scientific founder and California Institute of Technology (Caltech) Professor, Sarkis Mazmanian, Ph.D., will be...

Read more
By: Kairos Ventures On: April 2, 2022 In: Neuro-Bio, Portfolio News

British scientists believe they may have discovered the first effective treatment for dementia. Researchers at Neuro-Bio say their potential remedy...

Read more
By: Kairos Ventures On: March 24, 2022 In: MemVerge, Portfolio News

Liqid announced it is collaborating with big memory solutions pioneer MemVerge and technology industry leader Intel to deliver composable...

Read more
By: Kairos Ventures On: March 22, 2022 In: Portfolio News, Provivi

Provivi and Syngenta Crop Protection announce the commercialization of Nelvium™ to effectively and more safely control detrimental pests in...

Read more